.

 

J. B. Chemicals & Pharmaceuticals Ltd. (JBCPL), known to many as Unique Pharmaceutical Laboratories is one of India’s leading global pharmaceutical companies. The company manufactures and markets a wide range of pharmaceutical formulations, herbal remedies, bulk drugs, intermediates and radio-diagnostics.

 

   
name :
    email :
         


BSE
| NSE





Unaudited Results for the quarter ended on June 30, 2010new

Press Release- J.B.Chemicals posts healthy performance in Q1new

Press Release- Launch of 'Definity'new

Presentation to Analysts 14-07-2010new

Shareholding pattern for the quarter ended on June 30, 2010new

Annual General Meeting 2010new

Annual Report for 09-10new

Audited Financial Results for the year ended on March 31, 2010

Press Release for the
year ended on March 31,2010

Shareholding pattern for the quarter ended on March 31, 2010

Press Release for the quarter ended on December 31, 2009

Standalone Unaudited Financial Results For The Quarter Ended
31st December, 2009

Shareholding pattern as on 31/12/09

Board Meeting

Standalone Unaudited financial results for the quarter ended on September 30, 2009

Press Release –
Unaudited financial results September 09


Shareholding pattern for the quarter ended on September 30, 2009


Press Release –
Unaudited financial results June 09


Unaudited financial results June 09

Shareholding pattern as on 30/06/09


Annual Report 2008-09




Press Release- J.B.Chemicals posts healthy performance in Q1

Press Release- Launch of 'Definity'

Presentation to Analysts 14-07-2010

Shareholding pattern for the quarter ended on June 30, 2010

Annual General Meeting 2010

Annual Report for 09-10

Press Release for the year ended on March 31,2010

Press Release for the quarter ended on December 31, 2009

Press Release –
Unaudited financial results
September 09

Press Release
Unaudited Results Q1 0910

Press Release - JBCPL Board recommends 50% dividend

Press Release - Audited Results
2008-09

more news..
Copyright © 2005 J. B. Chemicals & Pharmaceuticals Ltd. All rights reserved.